Newron Pharmaceuticals SPA (GM) (NWPHF)
USOTC
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
総売上 | 6.73M | 13.43M | 4.03M | 7.04M | 5.26M | 5.76M | 6.09M | 9.06M |
営業利益 | -15.33M | -4.35M | -14.66M | -20.9M | -18.07M | -12.36M | -13.3M | -11.63M |
税引前収入 | -15.2M | -5.3M | -15.02M | -20.16M | -19.62M | -14.88M | -17.47M | -16.2M |
純利益 | -15.24M | -5.28M | -15.04M | -20.21M | -21M | -14.9M | -17.49M | -16.22M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.966 | -0.335 | -0.843 | -1.132 | -1.177 | -0.835 | -0.98 | -0.909 |
EBIT | -15.33M | -4.35M | -14.98M | -20.9M | -18.07M | -12.36M | -13.3M | -11.63M |
EBITDA | -15.29M | -4.05M | -14.61M | -20.9M | -17.92M | -12.2M | -13.14M | -11.57M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約